The effect of the glucagon-like peptide-1 analogue, liraglutide (Victoza®), on jejunostomy output and intestinal absorption in short bowel syndrome patients, a double-blind cross-over study.
Phase of Trial: Phase II
Latest Information Update: 27 Apr 2017
At a glance
- Drugs Liraglutide (Primary)
- Indications Short bowel syndrome
- Focus Pharmacokinetics
- 20 Dec 2016 New trial record